© 2021 MJH Life Sciences and Cure Today. All rights reserved.
© 2021 MJH Life Sciences™ and Cure Today. All rights reserved.
Enhancing lives and empowering patients by closing the existing gap from initial diagnosis to immediate and expanded access to advanced treatment, clinical trials, and critical care
May 13, 2020
The EndBrainCancer Initiative wants patient concerns reflected in national treatment guidelines.
March 29, 2016
May 28, 2015
2015 started off with a bang, with a focus on brain cancer patients and new treatment options for recurrent glioblastoma (rGBM).
Trial to Investigate Experimental Drug’s Effect on Improving Survival in Refractory Myelofibrosis
Early Study Results Show Novel Therapy Safe and Effective in Relapsed/Refractory Acute Myeloid Leukemia
My Nemesis the Gold-Capped Vial
Patients with Hematologic Cancers Benefit from a Walking Program